We are live on
!
Find out more
CMMB
Chemomab Therapeutics
CMMB
CMMB
14 hedge funds and large institutions have $606K invested in Chemomab Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
40% more funds holding
Funds holding: 10 → 14 (+4)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
1.58% less ownership
Funds ownership: 7.54% → 5.97% (-1.6%)
41% less capital invested
Capital invested by funds: $1.03M → $606K (-$420K)
Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$275K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$212K |
| 3 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
+$137K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$50.4K |
| 5 |
VF
Virtu Financial
New York
|
+$29K |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$472K |
| 2 |
Morgan Stanley
New York
|
-$229K |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$78.9K |
| 4 |
Jane Street
New York
|
-$15.7K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3.9K |
